Esmelinda, Baby Boy .

HRN: 28-73-60  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/26/2026
04/02/2026
IV
37mg
Q24H
Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: